Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
09-11 April, 2025
Not Confirmed
Not Confirmed
01-03 April, 2025
Peptide-Based Therapeu...Peptide-Based Therapeutics Summit
Not Confirmed
Not Confirmed
01-03 April, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
09-11 April, 2025
Industry Trade Show
Not Confirmed
01-03 April, 2025
Peptide-Based Therapeu...Peptide-Based Therapeutics Summit
Industry Trade Show
Not Confirmed
01-03 April, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/molecular-glue-degraders-lilly-abbvie-sign-billion-dollar-deals-bms-leads-with-three-late-stage-drugs
25 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/25/3048418/0/en/Alumis-and-Kaken-Pharmaceutical-Announce-Collaboration-and-Licensing-Agreement-for-ESK-001-in-Dermatology-in-Japan.html
19 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/19/3045800/0/en/Alumis-Reports-Year-End-2024-Financial-Results-and-Highlights-Recent-Achievements.html
10 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/10/3039679/0/en/Alumis-to-Present-at-Leerink-s-2025-Global-Healthcare-Conference.html
08 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/08/3039351/0/en/Late-Breaking-ESK-001-Phase-2-OLE-Data-Presented-at-2025-AAD-Annual-Meeting-Demonstrate-Robust-Clinical-Responses-Over-52-Weeks-in-Psoriasis.html
06 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/04/3036580/0/en/ACELYRIN-Determines-Unsolicited-Indication-of-Interest-From-Concentra-Biosciences-Not-Reasonably-Expected-to-Result-in-a-Superior-Proposal-to-Planned-Alumis-Merger.html
28 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/28/3034797/0/en/Alumis-Announces-Late-Breaker-Psoriasis-Presentation-of-52-week-Phase-2-OLE-Data-for-ESK-001-at-2025-American-Academy-of-Dermatology-Annual-Meeting-and-Accelerated-Topline-Phase-3-.html
ABOUT THIS PAGE